Status:
UNKNOWN
Noninvasive and Dynamic Monitoring the Biological Parameters of Eyes in Different Age Groups
Lead Sponsor:
Zhongnan Hospital
Conditions:
Myopia
Eligibility:
All Genders
12-35 years
Brief Summary
Myopia is the most common refractive eye disease worldwide. The number of cases is up to 2 billion. In recent years, the incidence of myopia in China is obviously rising trend. As early as the 2018 na...
Detailed Description
The Department of Ophthalmology, Zhongnan Hospital of Wuhan University, has a variety of the most advanced instruments and equipment in the world, such as the newly listed TOMEY CASIA2, which is non-i...
Eligibility Criteria
Inclusion
- Resident population in Hubei Province
- No gender preference
- Healthy population aged between 12 and 35
Exclusion
- Systemic diseases
- History of other eye diseases, surgery and/or medications, and eye trauma
- Anisometropia \> 2.00 D
- Astigmatism \> 2.00 D
- The best corrected visual acuity was less than 0.8
Key Trial Info
Start Date :
February 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT05250440
Start Date
February 1 2022
End Date
December 31 2024
Last Update
March 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China, 430071